2245 related articles for article (PubMed ID: 23711909)
21. [Analysis of copy number variations in 66 children with unexplained mental retardation/developmental delay using chromosomal microarrays].
Li Y; Qiu W; Ye J; Han L; Zhang H; Gu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Dec; 31(6):703-7. PubMed ID: 25449071
[TBL] [Abstract][Full Text] [Related]
22. Array CGH in patients with developmental delay or intellectual disability: are there phenotypic clues to pathogenic copy number variants?
Shoukier M; Klein N; Auber B; Wickert J; Schröder J; Zoll B; Burfeind P; Bartels I; Alsat EA; Lingen M; Grzmil P; Schulze S; Keyser J; Weise D; Borchers M; Hobbiebrunken E; Röbl M; Gärtner J; Brockmann K; Zirn B
Clin Genet; 2013 Jan; 83(1):53-65. PubMed ID: 22283495
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.
Roberts JL; Hovanes K; Dasouki M; Manzardo AM; Butler MG
Gene; 2014 Feb; 535(1):70-8. PubMed ID: 24188901
[TBL] [Abstract][Full Text] [Related]
24. Recurrent benign copy number variants & issues in interpretation of variants of unknown significance identified by cytogenetic microarray in Indian patients with intellectual disability.
Boggula VR; Agarwal M; Kumar R; Awasthi S; Phadke SR
Indian J Med Res; 2015 Dec; 142(6):699-712. PubMed ID: 26831419
[TBL] [Abstract][Full Text] [Related]
25. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal Microarray Testing in 42 Korean Patients with Unexplained Developmental Delay, Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies.
Lee SH; Song WJ
Genomics Inform; 2017 Sep; 15(3):82-86. PubMed ID: 29020723
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal Aberrations in Pediatric Patients With Moderate/Severe Developmental Delay/Intellectual Disability With Abundant Phenotypic Heterogeneities: A Single-Center Study.
Wu D; Wu Y; Lan Y; Lan S; Zhong Z; Li D; Zheng Z; Wang H; Ma L
Pediatr Neurol; 2023 Oct; 147():72-81. PubMed ID: 37566956
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal microarray testing influences medical management.
Coulter ME; Miller DT; Harris DJ; Hawley P; Picker J; Roberts AE; Sobeih MM; Irons M
Genet Med; 2011 Sep; 13(9):770-6. PubMed ID: 21716121
[TBL] [Abstract][Full Text] [Related]
29. Phenotype comparison among individuals with developmental delay/intellectual disability with or without genomic imbalances.
de Souza LC; Dos Santos AP; Sgardioli IC; Viguetti-Campos NL; Marques Prota JR; de Oliveira-Sobrinho RP; Vieira TP; Gil-da-Silva-Lopes VL
J Intellect Disabil Res; 2019 Nov; 63(11):1379-1389. PubMed ID: 30900361
[TBL] [Abstract][Full Text] [Related]
30. Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genes.
Di Gregorio E; Riberi E; Belligni EF; Biamino E; Spielmann M; Ala U; Calcia A; Bagnasco I; Carli D; Gai G; Giordano M; Guala A; Keller R; Mandrile G; Arduino C; Maffè A; Naretto VG; Sirchia F; Sorasio L; Ungari S; Zonta A; Zacchetti G; Talarico F; Pappi P; Cavalieri S; Giorgio E; Mancini C; Ferrero M; Brussino A; Savin E; Gandione M; Pelle A; Giachino DF; De Marchi M; Restagno G; Provero P; Cirillo Silengo M; Grosso E; Buxbaum JD; Pasini B; De Rubeis S; Brusco A; Ferrero GB
Clin Genet; 2017 Oct; 92(4):415-422. PubMed ID: 28295210
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal microarray analysis in developmental delay and intellectual disability with comorbid conditions.
Fan Y; Wu Y; Wang L; Wang Y; Gong Z; Qiu W; Wang J; Zhang H; Ji X; Ye J; Han L; Jin X; Shen Y; Li F; Xiao B; Liang L; Zhang X; Liu X; Gu X; Yu Y
BMC Med Genomics; 2018 May; 11(1):49. PubMed ID: 29793483
[TBL] [Abstract][Full Text] [Related]
32. Genetic profile and clinical application of chromosomal microarray in children with intellectual disability in Hong Kong.
Chan PY; Luk HM; Lee FM; Lo IF
Hong Kong Med J; 2018 Oct; 24(5):451-459. PubMed ID: 30262673
[TBL] [Abstract][Full Text] [Related]
33. [The diagnostic value of chromosome microarray analysis technique in the genetic causes of children with intellectual disability or global developmental delay].
Wu HR; Li L; Ma YN; Liu CL; Pei P; Zheng XF; Wang ST; Xiao Y; Bu DF; Xu YF; Pan H; Qi Y
Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(3):224-228. PubMed ID: 33455150
[No Abstract] [Full Text] [Related]
34. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
[TBL] [Abstract][Full Text] [Related]
35. Updates in the genetic evaluation of the child with global developmental delay or intellectual disability.
Flore LA; Milunsky JM
Semin Pediatr Neurol; 2012 Dec; 19(4):173-80. PubMed ID: 23245550
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
[TBL] [Abstract][Full Text] [Related]
37. Array-CGH analysis in patients with intellectual disability and/or congenital malformations in Brazil.
Vianna GS; Medeiros PF; Alves AF; Silva TO; Jehee FS
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909975
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal Microarray in Children With Developmental Delay: The Experience of a Tertiary Center in Korea.
Yang EH; Shin YB; Choi SH; Yoo HW; Kim HY; Kwak MJ; Park KH; Bae MH; Kong JH; Lee YJ; Nam SO; Kim YM
Front Pediatr; 2021; 9():690493. PubMed ID: 34604135
[No Abstract] [Full Text] [Related]
39. [Molecular diagnosis of children with unexplained intellectual disability/ developmental delay by array-CGH].
He XY; Chen XC; Li R; Li P; Lu AM
Zhongguo Dang Dai Er Ke Za Zhi; 2015 May; 17(5):459-63. PubMed ID: 26014695
[TBL] [Abstract][Full Text] [Related]
40. Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability.
Li Y; Anderson LA; Ginns EI; Devlin JJ
Mol Diagn Ther; 2018 Feb; 22(1):129-138. PubMed ID: 29209992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
